An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation.
Saved in:
| Title: | An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation. |
|---|---|
| Authors: | Park S; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea.; Interdisciplinary Program in Cancer Biology Major, Seoul National University College of Medicine, Seoul, Republic of Korea., Choi J; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University, Seoul, Republic of Korea., Lee Y; Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea., Noh J; Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea.; Bio-MAX Institute, Seoul National University, Seoul, Republic of Korea., Kim N; Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea., Lee J; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Republic of Korea., Cho G; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim S; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Yoo DK; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Kang CK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Choe PG; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim NJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Park WB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim S; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Republic of Korea. seungtaek.kim@ip-korea.org., Oh MD; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. mdohmd@snu.ac.kr., Kwon S; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea. skwon@snu.ac.kr.; Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea. skwon@snu.ac.kr.; Bio-MAX Institute, Seoul National University, Seoul, Republic of Korea. skwon@snu.ac.kr., Chung J; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea. jjhchung@snu.ac.kr.; Interdisciplinary Program in Cancer Biology Major, Seoul National University College of Medicine, Seoul, Republic of Korea. jjhchung@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. jjhchung@snu.ac.kr. |
| Source: | Nature communications [Nat Commun] 2024 Apr 20; Vol. 15 (1), pp. 3368. Date of Electronic Publication: 2024 Apr 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-47743-1 |
